Roth Capital Starts Mast Therapeutics (MSTX) at Buy
Tweet
Share
E-mailGet Alerts MSTX Hot Sheet
Price: $8.14 -5.35%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
Roth Capital initiated coverage on Mast Therapeutics (NYSE: MSTX) with a Buy rating and a price target of $3.00.
For an analyst ratings summary and ratings history on Mast Therapeutics click here. For more ratings news on Mast Therapeutics click here.
Shares of Mast Therapeutics closed at $0.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Arrowhead Pharma (ARWR) at Buy
- Trump: Reinstating The Iranian Blockade
- U.S. began launching strikes against Iran today - Bloomberg
Create E-mail Alert Related Categories
Hot New Coverage, Momentum Movers, New Coverage, Trader TalkRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
